STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LUPUS RESEARCH ALLIANCE INC: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
LUPUS RESEARCH ALLIANCE INC (EIN 58-2492929)
Tax period
2022-01-01 to 2022-12-31
Filed
2023-09-15
IRS object ID
202322589349302062
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-09-15T15:00:40-05:00ReturnTs
Tax Period End2022-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN131655065PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1LUTZ AND CARR CPAS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1551 FIFTH AVENUE SUITE 400AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10176ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2022-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN582492929EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUPUS RESEARCH ALLIANCE INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlLUPUBusinessNameControlTxt
Phone2122182840PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonDEBRA ROSEPersonNm
Person TitleVP AND CHIEF FINANCIAL OFFICERPersonTitleTxt
Phone2122182840PhoneNum
Signature2023-09-15SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstDEBRAPersonFirstNm
Person LastROSEPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info Curr0IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJENNIFER COATESPreparerPersonNm
PTINP02247728PTIN
Phone2126972299PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerALBERT T ROYPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$32,841,344GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressLUPUSRESEARCH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1999FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionFREEING THE WORLD OF LUPUS.ActivityOrMissionDesc
Voting Members Governing Body24VotingMembersGoverningBodyCnt
Voting Members Independent24VotingMembersIndependentCnt
Total Employee63TotalEmployeeCnt
Total Volunteers500TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$18,941,837PYContributionsGrantsAmt
CY Contributions Grants$18,375,553CYContributionsGrantsAmt
PY Program Service Revenue$1,036,685PYProgramServiceRevenueAmt
CY Program Service Revenue$1,232,995CYProgramServiceRevenueAmt
PY Investment Income$3,679,888PYInvestmentIncomeAmt
CY Investment Income$2,452,805CYInvestmentIncomeAmt
PY Other Revenue$121,620PYOtherRevenueAmt
CY Other Revenue$638,138CYOtherRevenueAmt
PY Total Revenue$23,780,030PYTotalRevenueAmt
CY Total Revenue$22,699,491CYTotalRevenueAmt
PY Grants And Similar Paid$15,031,432PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$17,377,279CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$6,237,294PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$7,532,779CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$65,000PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$65,000CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$3,074,858CYTotalFundraisingExpenseAmt
PY Other Expenses$5,438,357PYOtherExpensesAmt
CY Other Expenses$7,398,867CYOtherExpensesAmt
PY Total Expenses$26,772,083PYTotalExpensesAmt
CY Total Expenses$32,373,925CYTotalExpensesAmt
PY Revenues Less Expenses-$2,992,053PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$9,674,434CYRevenuesLessExpensesAmt
Total Assets BOY$110,909,946TotalAssetsBOYAmt
Total Assets EOY$98,907,292TotalAssetsEOYAmt
Total Liabilities BOY$41,423,828TotalLiabilitiesBOYAmt
Total Liabilities EOY$35,375,707TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$69,486,118NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$63,531,585NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionPUTTING PEOPLE WITH LUPUS AT THE CENTER OF ALL WE DO, THE LUPUS RESEARCH ALLIANCE DRIVES THE DISCOVERY & DEVELOPMENT OF NEXT GENERATION LUPUS DIAGNOSTICS AND CURATIVE TREATMENTS THROUGH INNOVATIVE RESEARCH & COLLABORATIONS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$18,280,972ExpenseAmt
Grant$17,187,962GrantAmt
DescRESEARCH:THE LUPUS RESEARCH ALLIANCE (LRA) IS THE LARGEST NON-GOVERNMENTAL, NON-PROFIT FUNDER OF LUPUS RESEARCH WORLDWIDE. THE ORGANIZATION AIMS TO TRANSFORM TREATMENT BY FUNDING THE MOST INNOVATIVE LUPUS RESEARCH, FOSTERING DIVERSE SCIENTIFIC TALENT, AND DRIVING DISCOVERY TOWARD BETTER DIAGNOSTICS AND IMPROVED TREATMENTS. LRA-FUNDED RESEARCH IS LEADING TO KEY DISCOVERIES THAT ARE IMPROVING DIAGNOSIS AND THERAPIES WHILE ADVANCING TOWARD PREVENTION AND ULTIMATELY A CURE. THE ORGANIZATION'S RESEARCH COMMITTEE OF THE BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD INCLUDE TOP SCIENTIFIC EXPERTS, AND KEY LAY MEMBERS OF THE BOARD, WHO WORK WITH STAFF TO STRATEGICALLY GUIDE AND DRIVE THE RESEARCH FUNDING AGENDA. SINCE ITS INCEPTION, THE LRA HAS COMMITTED OVER $245 MILLION TO FUND LUPUS RESEARCH PROJECTS. IN 2022 ALONE, OVER $17,000,000 WAS AWARDED IN GRANTS FOR HIGHLY INNOVATIVE PROJECTS WITH THE POTENTIAL TO IMPROVE TREATMENT AS WELL AS UNDERSTAND THE CAUSES OF LUPUS AND THUS LEAD TO A CURE. BELOW IS A SUMMARY OF RESEARCH GRANTS AND PROGRAMS FUNDED BY THE LRA IN 2022: 1) 3 GLOBAL TEAM SCIENCE AWARDS WERE AWARDED FOR $3 MILLION FOR A TOTAL OF $9 MILLION OVER TWO YEARS. THESE AWARDS WILL FUND MULTIDISCIPLINARY, COLLABORATIVE AND HIGHLY SYNERGISTIC PROJECTS THAT PUSH THE BOUNDARIES OF INNOVATION AND BRIDGE RESEARCH AND CLINICAL EFFORTS IN LUPUS. THE TEAMS WILL FOCUS ON UNRAVELING HUMAN LUPUS HETEROGENEITY WITH THE AIM TO DISCOVER NEW AVENUES TO PERSONAL TREATMENT APPROACHES; 2) 7 LUPUS INNOVATION AWARD GRANTS WERE AWARDED TOTALING OVER $2 MILLION OVER TWO YEARS, THIS PROGRAM PROVIDES EARLY-STAGE SUPPORT FOR EXCEPTIONALLY CREATIVE AND INNOVATIVE APPROACHES TO MAJOR CHALLENGES IN LUPUS RESEARCH; 3) 4 LUPUS MECHANISMS AND TARGETS AWARDS TOTALING $2.4 MILLION TO SUPPORT ESTABLISHED INVESTIGATORS FOCUSED ON CHARACTERIZING LUPUS PATHOGENESIS AND IDENTIFYING AND VALIDATING MOLECULAR PATHWAYS OR DRUGGABLE TARGETS THAT COULD LEAD TO NEW OR IMPROVED THERAPIES.4) THE PACE OF FUNDING IN THE DIVERSITY IN LUPUS RESEARCH PROGRAM GAINED MOMENTUM 2022 BY FUNDING THE FOLLOWING: A. 4 ADMINISTRATIVE DIVERSITY SUPPLEMENT GRANTS TO PROMOTE DIVERSITY IN LUPUS RESEARCH WERE AWARDED TOTALING APPROXIMATELY $120,000. THESE AWARDS FUND HIGHLY QUALIFIED AND PROMISING UNDERREPRESENTED MINORITY TRAINEES TO SUPPORT THEIR RESEARCH EXPERIENCES ALIGNED WITH AN LRA PARENT AWARD. B. 3 GRANTS WERE AWARDED TO RESEARCHERS IN THE CAREER DEVELOPMENT AWARD PROGRAM THAT AIMS TO FOSTER THE DEVELOPMENT OF OUTSTANDING, UNDERREPRESENTED MINORITY SCIENTISTS AND ESTABLISH A DIVERSE COMMUNITY OF RESEARCHERS AND CLINICIANS IN THE FIELD OF LUPUS, THE PROGRAM PROVIDES UP TO $600,000 OVER FOUR YEARS TO TALENTED UNDERREPRESENTED MINORITY SCIENTISTS.C. 2 POSTDOCTORAL GRANTS FELLOWSHIP GRANTS WHICH PROVIDE FELLOWS WITH UP TO $170,000 OVER TWO YEARS TO SUPPORT THE GENERATION OF DATA AND PROGRESS NEEDED TO BECOME INDEPENDENT LUPUS RESEARCHERS.5) THE DISTINGUISHED INNOVATOR AWARD PROGRAM PROVIDES OUTSTANDING SCIENTISTS WITH SUBSTANTIAL SUPPORT TO CONDUCT HIGHLY INNOVATIVE RESEARCH TO UNCOVER THE UNDERLYING CAUSES OF LUPUS, 2 DISTINGUISHED INNOVATOR AWARDS FOR A TOTAL OF $2 MILLION WERE AWARDED OVER FOUR YEARS TO HIGHLY QUALIFIED INVESTIGATORS TO COMPLETE THE PROPOSED WORK.6) THE LUPUS INSIGHT PRIZE WAS AWARDED FOR $100,000. THIS AWARD RECOGNIZES A LEADING RESEARCHER WHO HAS MADE A MAJOR CONTRIBUTION TO THE FIELD. 7) CONTINUED FUNDING FOR TWO GRANTS AS PART OF OUR PARTNERSHIP WITH OTHER ORGANIZATIONS FOCUSED ON FINDING COMMON MECHANISMS IN AUTOIMMUNE DISEASES. THE LRA'S UNIQUE FUNDING MODEL SUPPORTS PROMISING RESEARCH EFFORTS WITH THE GOAL OF IMPROVING THE LIVES OF PEOPLE WITH LUPUS IN THE NEAR FUTURE. THROUGH A COMPETITIVE PEER-REVIEW PROCESS PROJECTS BY THE LRA AIM TO TRANSLATE RESULTS FROM THE RESEARCH BENCH TO THE BEDSIDE AS QUICKLY AS POSSIBLE. BECAUSE THE LUPUS RESEARCH ALLIANCE'S BOARD OF DIRECTORS FUNDS THE ADMINISTRATIVE AND FUNDRAISING EXPENSES, 100% OF ALL OTHER CONTRIBUTIONS GOES TO SUPPORT THE LRA'S LUPUS RESEARCH PROGRAMS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$7,351,943ExpenseAmt
Grant$107,085GrantAmt
Revenue$1,232,995RevenueAmt
DescSCIENTIFIC PROGRAMS:LUPUS RESEARCH ALLIANCE'S (LRA) SCIENTIFIC PROGRAM CONTINUED TO GROW IN 2022. THIS GROWTH WAS SPURRED BY BUILDING ON ESTABLISHED PROGRAMS AND FINDING WAYS TO CONTINUE TO EXPAND WHILE CREATING OPPORTUNITIES FOR COLLABORATION WITH DIFFERENT SECTORS. AN EXAMPLE OF THIS YEAR'S ACCOMPLISHMENTS ARE LISTED BELOW: COLLABORATED WITH LRA RESEARCH COMMITTEE OF THE BOARD AND SCIENTIFIC ADVISORY BOARD TO CONTINUE TO IMPLEMENT EFFICIENTLY OUR RESEARCH STRATEGY INTO IMPORTANT SCIENTIFIC TOOLS, PROGRAMS, AND PARTNERSHIPS AND MOVE CLOSER TO ACHIEVING LRA'S MISSION. LAUNCHED THE DIVERSITY IN LUPUS RESEARCH PROGRAM BY FUNDING FIVE INAUGURAL GRANT AWARDS. SOLIDIFIED THE SCIENTIFIC STRENGTH AND POTENTIAL OF THE GLOBAL TEAM SCIENCE AWARD BY FUNDING THREE ADDITIONAL TEAMS REPRESENTING FIVE CONTINENTS AND TACKLING A BREADTH OF KEY ISSUES IN LUPUS FROM COGNITIVE IMPAIRMENT, DISEASE REMISSION, GUT MICROBIOME, AND ANCESTRAL DRIVERS OF DISEASE. ESTABLISHMENT OF A PUBLIC PRIVATE PARTNERSHIP WITH THE FDA ON LUPUS CALLED THE LUPUS ACCELERATING BREAKTHROUGHS CONSORTIUM (LUPUS ABC). CONTINUED TO ESTABLISH KEY INFRASTRUCTURE COMPONENTS OF THE LUPUS NEXUS (LRA'S LUPUS REGISTRY AND BIOREPOSITORY) THE CLINICAL STUDY PROTOCOL (THE LUPUS LANDMARK STUDY). WORKING WITH LUPUS THERAPEUTICS, LUPUS NEXUS WILL CAPITALIZE ON CURRENT STRATEGIC OPPORTUNITIES IN THE LUPUS FIELD BY ENABLING A COLLABORATIVE, DATA-DRIVEN PLATFORM FOR THE RESEARCH COMMUNITY. THE VISION FOR THE LUPUS NEXUS IS TO TRANSFORM LUPUS RESEARCH AND DRUG DEVELOPMENT THROUGH UNPRECEDENTED INFORMATION EXCHANGE CAPABILITIES. THE PLATFORM WILL PROVIDE A COLLABORATIVE SOLUTION THAT IS INCLUSIVE OF DIVERSE PATIENT POPULATIONS DISPROPORTIONATELY AFFECTED BY LUPUS. THE LUPUS NEXUS WILL BE A SOURCE OF HIGHLY CURATED DATA TO CATALYZE GLOBAL COLLABORATION, RESEARCH INNOVATION, AND PRECISION MEDICINE APPROACHES TO ACCELERATE LUPUS RESEARCH AND DRUG DEVELOPMENT. EXPANDED LRA'S RESEARCH PORTFOLIO WITH NEW, INNOVATIVE, AND POTENTIALLY IMPACTFUL RESEARCH PROJECTS: TWO DISTINGUISHED INNOVATOR AWARDS, FOUR LUPUS MECHANISMS AND TARGETS AWARD, AND SEVEN LUPUS INNOVATION AWARDS. ALSO FURTHER OPTIMIZED THE LUPUS INSIGHT PRIZE PROGRAM TO STIMULATE THE SUBMISSION OF A ROBUST POOL OF COMPELLING NOMINATIONS. MAINTAINED A STRONG ENGAGEMENT OF THE LUPUS INDUSTRY COUNCIL THROUGH THE LUPUS ABC, LUPUS NEXUS, AND THE BICLA/SRI-4 PROJECT. THE LATTER WAS PRESENTED AT THE NOVEMBER 2022 ANNUAL COLLEGE OF RHEUMATOLOGY MEETING. AS PART OF THE LRA'S COMMITMENT TO CROSS-SECTOR AND CROSS-DISCIPLINE PARTNERSHIPS TO FOSTER THE MOST INNOVATIVE AND PRODUCTIVE RESEARCH ENVIRONMENT, BOLSTERED LRA'S CONVENING POWER AND SPEARHEAD NEW THINKING ABOUT A KEY AREA IN LUPUS RESEARCH BY ORGANIZING AND CONVENING A HIGHLY SUCCESSFUL SCIENTIFIC MEETING ON THE "IMPACT OF ANCESTRY, RACE, AND RACIAL INEQUALITIES ON LUPUS." CONTINUED TO NURTURE COLLABORATION BY HOSTING INTERNAL AND EXTERNAL MEETINGS. THIS INCLUDED RESEARCH COMMITTEE MEETINGS WHERE MEMBERS OF OUR BOARD OF DIRECTORS AS WELL AS TOP-LEVEL RESEARCHERS DISCUSSED OUR PORTFOLIO AND UPCOMING STRATEGIC STEPS; SCIENTIFIC ADVISORY BOARD MEETINGS WHERE HIGHLY REGARDED SCIENTIFIC ADVISORS REVIEW GRANT APPLICATION SUBMISSIONS AND DISCUSS FUTURE AND OVERALL RESEARCH STRATEGY FOR THE ORGANIZATION; GRANT SPECIFIC STUDY SECTIONS WHERE INVITED RESEARCHERS DISCUSSED AND REVIEWED APPLICATIONS SUBMITTED TO THE LRA. THE LRA FOUNDED LUPUS THERAPEUTICS, LLC AS AN AFFILIATE OF THE LRA IN 2018 TO RUN LUCIN TO ADVANCE CLINICAL TRIALS AND FACILITATE THE DEVELOPMENT OF MUCH NEEDED NEW LUPUS TREATMENTS. THE LRA COMMITTED OVER $4.3 MILLION IN 1-YEAR GRANTS IN 2021 TO CONTINUE FUNDING THRU 2023 OF TOP ACADEMIC CENTERS TO FOSTER CLINICAL TRIAL PARTICIPATION IN LUCIN. LUPUS THERAPEUTICS (LT) IS COMMITTED TO DELIVERING CUSTOMIZED SERVICES AND BY PARTNERING WITH AND LEVERAGING THE EXPERTS WITHIN OUR NORTH AMERICAN-BASED LUPUS CLINICAL INVESTIGATORS NETWORK (LUCIN) AND THOSE IMPACTED BY LUPUS, LT STRIVES TO OPTIMIZE ENGAGEMENT AND DRIVE RESULTS. LT CUSTOMIZED SERVICES ARE FOCUSED ON ENGAGING THE LUPUS PATIENT AND SCIENTIFIC COMMUNITY AS KEY CONTRIBUTORS TO DRUG DEVELOPMENT ENDEAVORS TO INCREASE THE PROBABILITY OF STUDY SUCCESS. LT'S VALUE PROPOSITION INCLUDES -BROAD FOOTPRINT WITHIN THE LUPUS PATIENT COMMUNITY -PARTNERS WITH >200 LUPUS KOLS AND NORTH AMERICAN ACADEMIC CENTERS OF EXCELLENCE -FINANCIAL AND COMMUNITY INCENTIVES FOR SITES THAT PRIORITIZE LUCIN-SANCTIONED STUDIES -ACCELERATED STUDY START-UP TIMELINES AND SUPPORT THROUGHOUT STUDY CONDUCT -FACILITATION OF RELATIONSHIPS AND MUTUAL TRUST BETWEEN SITES AND SPONSORSDesc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$642,971ExpenseAmt
Grant$82,232GrantAmt
DescPUBLIC POLICY:THE MAIN GOALS OF THE LUPUS RESEARCH ALLIANCE PUBLIC POLICY PROGRAM ARE TO: EDUCATE MEMBERS OF CONGRESS ABOUT ISSUES OF PRIORITY TO THE LUPUS COMMUNITY; INCREASE FEDERAL FUNDING FOR LUPUS RESEARCH BY INCREASING OVERALL NATIONAL INSTITUTES OF HEALTH (NIH) FUNDS AND SECURE ADDITIONAL FUNDING FOR LUPUS RESEARCH THROUGH OTHER KEY FEDERAL AGENCIES INCLUDING THE DEPARTMENT OF DEFENSE (DOD); AND ENSURE THE PATIENT VOICE IS INCORPORATED IN THE DRUG DEVELOPMENT PROCESS. VOLUNTEERS ACROSS THE COUNTRY HELP AMPLIFY THESE OUTREACH EFFORTS.THROUGH THE LUPUS RESEARCH ALLIANCE ONGOING PUBLIC POLICY PROGRAM EFFORTS, SIGNIFICANT FUNDING FOR LUPUS RESEARCH HAS BEEN OBTAINED UNDER THE DEPARTMENT OF DEFENSE (DOD) CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS (CDMRP) OPERATED BY THE ARMY MEDICAL RESEARCH AND MATERIEL COMMAND. FIRST, THE LUPUS RESEARCH ALLIANCE WAS RESPONSIBLE FOR PERSUADING CONGRESS TO INCLUDE LUPUS IN ITS LIST OF DESIGNATED DISEASES ELIGIBLE FOR FUNDING IN THE PEER REVIEWED MEDICAL PROGRAM. IN 2017, LUPUS RESEARCH ALLIANCE ADVOCACY EFFORTS SUCCEEDED IN THE ESTABLISHMENT OF THE LUPUS RESEARCH PROGRAM UNDER THE CDMRP. OVER THE PROGRAM'S FIRST THREE YEARS, $5 MILLION WAS ALLOCATED EACH YEAR SPECIFICALLY FOR LUPUS; THROUGH THE LUPUS RESEARCH ALLIANCE'S CONTINUED EFFORTS, THIS AMOUNT WAS INCREASED TO $10M IN THE FISCAL YEAR (FY) 2020 DEFENSE APPROPRIATIONS BILL AND HAS CONTINUED AT THAT LEVEL THROUGH FY 2023. OVER SEVEN YEARS, $55M WAS SECURED UNDER THIS PROGRAM, AND THE LRA HAS REQUESTED AN INCREASE TO $15M FOR FY 2024.THE LRA COLLABORATED WITH THE LUPUS AND ALLIED DISEASES ASSOCIATION (LADA) AND LUPUS FOUNDATION OF AMERICA (LFA) IN 2017 ON THE LUPUS PATIENT-FOCUSED DRUG DEVELOPMENT (PFDD) INITIATIVE. THIS EFFORT CULMINATED IN A REPORT DESIGNED TO PROVIDE THE FOOD AND DRUG ADMINISTRATION (FDA) WITH PERSPECTIVES FROM PEOPLE WITH LUPUS, ADVOCATES, AND CAREGIVERS TO HELP INFORM THE FDA'S DECISIONS AND OVERSIGHT DURING THE DRUG DEVELOPMENT AND REVIEW PROCESSES. THE LRA CONTINUES TO WORK TO BRING THE VOICE OF THE COMMUNITY TO THE DRUG REVIEW PROCESS BY RESPONDING TO RELEVANT CALLS FROM THE FDA FOR COMMENTS INCLUDING THOSE FOCUSED ON ENSURING CLINICAL TRIAL PARTICIPANTS REPRESENT THE REAL-WORLD DEMOGRAPHIC CHARACTERISTICS OF PEOPLE LIVING WITH THE DISEASE. THE LRA HAS WORKED WITH MEMBERS OF CONGRESS TO INCLUDE LANGUAGE IN THE REPORT THAT ACCOMPANIES THE AGRICULTURE-RURAL DEVELOPMENT-FDA FUNDING BILL FOR FISCAL YEAR 2022 AND 2023.ONGOING ADVOCACY FOCUSES ON ENSURING LEGISLATION THAT SECURES THE FEDERAL FUNDING SUPPORT NECESSARY TO AFFORD INVESTIGATORS THE RESOURCES TO FOLLOW THROUGH WITH RESEARCH DISCOVERIES THAT WILL IMPROVE THE UNDERSTANDING OF AND TREATMENT FOR LUPUS. EVERY YEAR, THE LRA TRAINS AND ORGANIZES ADVOCATES FROM ACROSS THE COUNTRY TO MEET WITH LEGISLATORS ON CAPITOL HILL. THE GOAL IS TO INCREASE AWARENESS OF LUPUS AND THE IMPACT IT HAS ON PEOPLE'S DAILY LIVES TO MEMBERS OF CONGRESS AND TO REQUEST THEIR SUPPORT FOR INCREASED FUNDING FOR LUPUS RESEARCH FROM FEDERAL PROGRAMS SUCH AS THE NIH AND CDMRP.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$26,275,886TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional FundraisingYes (1)ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document97IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee63EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members24GoverningBodyVotingMembersCnt
Independent Voting Member24IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DEBRA ROSEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6468846000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (35 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
IRA AKSELRAD
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
RICHARD K DESCHERER
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
JOSEPH MAURIELLO
TREASURER1.00Yes (X)Yes (X)$0$0$0
BRENDA BLACKMON
SECRETARY1.00Yes (X)Yes (X)$0$0$0
BISHOP RUDY V CARLTON
DIRECTOR1.00Yes (X)$0$0$0
WILLIE COLON
DIRECTOR1.00Yes (X)$0$0$0
THOMAS O DANIEL
DIRECTOR1.00Yes (X)$0$0$0
JENNIE DESCHERER
DIRECTOR1.00Yes (X)$0$0$0
KATEY DRISCOLL
DIRECTOR1.00Yes (X)$0$0$0
SIR MARC FELDMANN
DIRECTOR1.00Yes (X)$0$0$0
MOTI FERDER
DIRECTOR1.00Yes (X)$0$0$0
JOE GERMANOTTA
DIRECTOR1.00Yes (X)$0$0$0
DAVID KIES
DIRECTOR1.00Yes (X)$0$0$0
DANIEL LAVECCHIA
DIRECTOR1.00Yes (X)$0$0$0
ANNA FISCH
DIRECTOR1.00Yes (X)$0$0$0
VERONICA VARGAS LUPO
DIRECTOR1.00Yes (X)$0$0$0
MOLLY MCCABE
DIRECTOR1.00Yes (X)$0$0$0
NADEEM MEGHJI
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM J MULVIHILL
DIRECTOR1.00Yes (X)$0$0$0
ROBERT SEDER MD
DIRECTOR1.00Yes (X)$0$0$0
DANIEL J WALLACE
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM WOLFE
DIRECTOR1.00Yes (X)$0$0$0
JULIUS WILLIAMS
DIRECTOR1.00Yes (X)$0$0$0
SPENCER ZWICK
DIRECTOR1.00Yes (X)$0$0$0
ALBERT ROY
CEO AND PRESIDENT40.00Yes (X)$336,203$0$84,123
KENNETH M FARBER
CEO AND PRESIDENT (PAST)40.00Yes (X)$406,576$0$62,583
DEBRA ROSE
VP AND CHIEF FINANCE OFFICER40.00Yes (X)$226,160$0$49,285
TEODORA STAEVA
VP AND CHIEF SCIENTIFIC OFFICER40.00Yes (X)$319,513$0$68,628
ANDREA O'NEILL
VP AND CHIEF DEVELOPMENT OFFICER40.00Yes (X)$278,423$0$51,244
PENELOPE MITCHELL
VP OF COMMUNICATIONS40.00$186,455$0$39,042Yes (X)
JONATHAN MARKS
DIRECTOR OF CORPORATE DEVELOPMENT40.00$148,131$0$51,381Yes (X)
DEVON KELLY
LUPUS NEXUS DIRECTOR40.00$159,801$0$37,410Yes (X)
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANTHROPY40.00$177,429$0$40,693Yes (X)
DIANE GROSS
NATIONAL DIRECTOR OF ADVOCACY40.00$145,081$0$47,054Yes (X)
EBONY SCOTT
HEALTH EQUITY DIRECTOR40.00$136,879$0$34,036Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,520,651TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$565,479TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K21IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
DELOITTE CONSULTING LLP
4022 SELLS DRIVEHERMITAGETN37076LUPUS NEXUS PLANNING CONSULTANT$414,344
CONVERGENCY LLC
1015 15TH ST 6TH FL NWWASHINGTONDC20005FDA CONSULTANT$300,000
EG&A CIRP DBA MCS HEALTHCARE PR
110 ALLEN RD 300BASKING RIDGENJ07921PUBLIC RELATIONS CONSULTANT$236,096
NKECHINYERE ANYADIKE
907 MILTON STREETRICHMONDVA23222LUPUS NEXUS CONSULTANT$146,240
SCHANER & LUBITZ PLLC
4550 MONTGOMERY AVE SUITE 1100 NBETHESDAMD20814LIFE SCIENCES ATTORNEY$118,588
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K9CntrctRcvdGreaterThan100KCnt
Fundraising$5,206,305FundraisingAmt
Government Grants$294,339GovernmentGrantsAmt
All Other Contributions$12,874,909AllOtherContributionsAmt
Noncash Contributions$270,634NoncashContributionsAmt
Total Contributions$18,375,553TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescLUCIN CONSULTING REVENUEDesc
Business900099BusinessCd
Total Revenue Column$1,232,995TotalRevenueColumnAmt
Related Or Exempt Func Income$1,232,995RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,232,995TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,017,764TotalRevenueColumnAmt
Exclusion$2,017,764ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$10,028,182SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$9,593,141SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$435,041SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$435,041TotalRevenueColumnAmt
Exclusion$435,041ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$548,712FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$5,206,305ContriRptFundraisingEventAmt
Fundraising Direct Expenses$548,712FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescSUBLET INCOMEDesc
Business900099BusinessCd
Total Revenue Column$638,138TotalRevenueColumnAmt
Exclusion$638,138ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$638,138OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$22,699,491TotalRevenueColumnAmt
Related Or Exempt Func Income$1,232,995RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$3,090,943ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$10,484,183TotalAmt
Program Services$10,484,183ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$82,232TotalAmt
Program Services$82,232ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$6,810,864TotalAmt
Program Services$6,810,864ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,882,737TotalAmt
Program Services$1,029,989ProgramServicesAmt
Management And General$399,334ManagementAndGeneralAmt
Fundraising$453,414FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$4,026,530TotalAmt
Program Services$2,278,712ProgramServicesAmt
Management And General$773,852ManagementAndGeneralAmt
Fundraising$973,966FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$290,856TotalAmt
Program Services$165,951ProgramServicesAmt
Management And General$53,041ManagementAndGeneralAmt
Fundraising$71,864FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$925,365TotalAmt
Program Services$521,636ProgramServicesAmt
Management And General$178,554ManagementAndGeneralAmt
Fundraising$225,175FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$407,291TotalAmt
Program Services$228,427ProgramServicesAmt
Management And General$80,297ManagementAndGeneralAmt
Fundraising$98,567FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$171,318TotalAmt
Program Services$112,851ProgramServicesAmt
Management And General$42,810ManagementAndGeneralAmt
Fundraising$15,657FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$66,298TotalAmt
Management And General$66,298ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$126,919TotalAmt
Program Services$126,919ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$65,000TotalAmt
Fundraising$65,000FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$226,555TotalAmt
Management And General$226,555ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,333,191TotalAmt
Program Services$1,536,431ProgramServicesAmt
Management And General$630,989ManagementAndGeneralAmt
Fundraising$165,771FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$120,275TotalAmt
Program Services$54,327ProgramServicesAmt
Management And General$44,173ManagementAndGeneralAmt
Fundraising$21,775FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$847,284TotalAmt
Program Services$599,362ProgramServicesAmt
Management And General$154,177ManagementAndGeneralAmt
Fundraising$93,745FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$948,653TotalAmt
Program Services$577,204ProgramServicesAmt
Management And General$166,752ManagementAndGeneralAmt
Fundraising$204,697FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$427,290TotalAmt
Program Services$293,239ProgramServicesAmt
Management And General$96,720ManagementAndGeneralAmt
Fundraising$37,331FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$984,350TotalAmt
Program Services$941,068ProgramServicesAmt
Management And General$10,249ManagementAndGeneralAmt
Fundraising$33,033FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$115,500TotalAmt
Program Services$64,777ProgramServicesAmt
Management And General$22,772ManagementAndGeneralAmt
Fundraising$27,951FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$56,333TotalAmt
Program Services$32,198ProgramServicesAmt
Management And General$10,835ManagementAndGeneralAmt
Fundraising$13,300FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PRINTING & PUBLICATIONS$308,530$36,965$12,470$259,095
CLINICAL STUDIES$197,416$197,416
POSTAGE, SHIPPING & DEL$134,996$7,967$21,460$105,569
DATA PROCESSING$127,051$32,997$12,835$81,219

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$206,908TotalAmt
Program Services$60,171ProgramServicesAmt
Management And General$19,008ManagementAndGeneralAmt
Fundraising$127,729FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$32,373,925TotalAmt
Program Services$26,275,886ProgramServicesAmt
Management And General$3,023,181ManagementAndGeneralAmt
Fundraising$3,074,858FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$12,383,714BOYAmt
EOY$5,098,361EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$847,554BOYAmt
EOY$864,824EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$2,944,619BOYAmt
EOY$1,416,005EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$332,914BOYAmt
EOY$626,727EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$370,260BOYAmt
EOY$567,776EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,114,140LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$884,288LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$275,664BOYAmt
EOY$229,852EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$92,239,618BOYAmt
EOY$85,820,065EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$1,025,732BOYAmt
EOY$1,033,847EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$489,871BOYAmt
EOY$3,249,835EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$110,909,946BOYAmt
EOY$98,907,292EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$763,708BOYAmt
EOY$878,056EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$39,844,509BOYAmt
EOY$29,652,068EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$42,880BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$772,731BOYAmt
EOY$4,845,583EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$41,423,828BOYAmt
EOY$35,375,707EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$58,936,120BOYAmt
EOY$61,152,445EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$10,549,998BOYAmt
EOY$2,379,140EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$69,486,118BOYAmt
EOY$63,531,585EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$110,909,946BOYAmt
EOY$98,907,292EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$9,674,434ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$7,913,885NetUnrlzdGainsLossesInvstAmt
Prior Period Adjustments$8,680,000PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$2,953,786OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$15,396,535CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$17,673,622CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$41,539,746CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$18,941,837CurrentTaxYearMinus1YearAmt
Current Tax Year$18,375,553CurrentTaxYearAmt
Total$111,927,293TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$15,396,535CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$17,673,622CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$41,539,746CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$18,941,837CurrentTaxYearMinus1YearAmt
Current Tax Year$18,375,553CurrentTaxYearAmt
Total$111,927,293TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$44,637,444SubstantialContributorsTotAmt
Public Support Total170$67,289,849PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,336,303CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,445,946CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,614,390CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,025,770CurrentTaxYearMinus1YearAmt
Current Tax Year$2,655,902CurrentTaxYearAmt
Total$9,078,311TotalAmt
FieldValueIRS element (for citing)
Total Support$121,005,604TotalSupportAmt
Gross Receipts Rltd Activities$6,131,797GrossReceiptsRltdActivitiesAmt
Public Support CY1700.55610PublicSupportCY170Pct
Public Support PY1700.51030PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$622,162FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$622,162FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$31,751,763FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$32,373,925FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$846,235CurrentYearMinus3Amt
Current Year Minus2$743,966CurrentYearMinus2Amt
Current Year Minus1$647,293CurrentYearMinus1Amt
Current Year$622,162CurrentYearAmt
Total$2,859,656TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$61,314,537BeginningYearBalanceAmt
Investment Earnings Or Losses-$3,669,040InvestmentEarningsOrLossesAmt
Other Expenditures$3,659,722OtherExpendituresAmt
End Year Balance$53,986,019EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$56,586,437BeginningYearBalanceAmt
Investment Earnings Or Losses$7,839,333InvestmentEarningsOrLossesAmt
Other Expenditures$3,111,233OtherExpendituresAmt
End Year Balance$61,314,537EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$51,813,456BeginningYearBalanceAmt
Investment Earnings Or Losses$6,226,708InvestmentEarningsOrLossesAmt
Other Expenditures$1,453,727OtherExpendituresAmt
End Year Balance$56,586,437EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$46,122,925BeginningYearBalanceAmt
Investment Earnings Or Losses$8,404,231InvestmentEarningsOrLossesAmt
Other Expenditures$2,713,456OtherExpendituresAmt
End Year Balance$51,813,456EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$51,742,397BeginningYearBalanceAmt
Investment Earnings Or Losses-$2,936,193InvestmentEarningsOrLossesAmt
Other Expenditures$2,683,279OtherExpendituresAmt
End Year Balance$46,122,925EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$416,504OtherCostOrOtherBasisAmt
Depreciation$265,620DepreciationAmt
Book Value$150,884BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$697,636OtherCostOrOtherBasisAmt
Depreciation$618,668DepreciationAmt
Book Value$78,968BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$229,852TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescOPERATING LEASE LIABILITYDesc
Amt$4,845,583Amt
FieldValueIRS element (for citing)
Total Liability$4,845,583TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$19,413,169TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst-$7,913,885NetUnrealizedGainsInvstAmt
Recoveries Prior Year Grants$4,854,118RecoveriesPriorYearGrantsAmt
Revenue Not Reported-$3,059,767RevenueNotReportedAmt
Revenue Subtotal$22,472,936RevenueSubtotalAmt
Investment Expenses Not Incld$226,555InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$226,555RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$22,699,491TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$34,047,702TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$1,910,103OtherExpensesIncludedAmt
Expenses Not Reported$1,910,103ExpensesNotReportedAmt
Expenses Subtotal$32,137,599ExpensesSubtotalAmt
Investment Expenses Not Incld2$226,555InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$9,771OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$236,326ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$32,373,925TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:BOARD DESIGNATED (QUASI) ENDOWMENT FUND INCOME TO BE USED FOR RESEARCH PROGRAM GRANTS. PRINCIPAL TO REMAIN INTACT UNLESS HIGH PRIORITY LUPUS RESEARCH PROJECTS NEED TO BE FUNDED THAT COULD NOT BE FUNDED OTHERWISE.
PART XII, LINE 2D - OTHER ADJUSTMENTS:IMPAIRMENT LOSS ON OPERATING LEASE RIGHT-OF-USE ASSET 1,910,103.
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURN OF GRANTS & ADJUSTMENTS 9,771.
PART PART XII, LINE 4BUNUSED PORTIONS OF GRANTS RETURNED TO LRA THAT WERE PAID IN PREVIOUS YEARS IN THE AMOUNT OF $9,771. THESE AMOUNTS ARE RECONCILING ITEMS BETWEEN THE REVENUE AND EXPENSES FROM THE AUDITED FINANCIAL STATEMENTS AND THOSE REPORTED ON FORM 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES00GRANTS TO RECIPIENTS$680,000
EAST ASIA AND THE PACIFIC00GRANTS TO RECIPIENTS$2,877,407
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM00GRANTS TO RECIPIENTS$3,253,457
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$6,810,864SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$6,810,864TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (11 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
NORTH AMERICALUPUS RESEARCH$660,000ACH$0
NORTH AMERICALUPUS RESEARCH$10,000ACH$0
NORTH AMERICALUPUS RESEARCH$10,000WIRE$0
EAST ASIA AND THE PACIFICLUPUS RESEARCH$2,827,071ACH$0
EAST ASIA AND THE PACIFICLUPUS RESEARCH$8,611WIRE$0
EAST ASIA AND THE PACIFICLUPUS RESEARCH$41,725WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$2,821,485WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$10,000WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$8,611WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$124,834WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$288,527WIRE$0
FieldValueIRS element (for citing)
Total501c3 Org3Total501c3OrgCnt
Total Other Org5TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:PRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, DURING THE APPLICATION PHASE, THE SPONSORING INSTITUTION (SI) MUST AGREE THAT THEY WILL AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S GRANT-SPECIFIC POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: A. CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. B. AGREE THAT PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THROUGHOUT THE PROJECT PERIOD. C. AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. D. AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. E. AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. F. TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING - FORUM FOR DISCOVERY. G. CONFIRMATION THAT THERE IS NO OTHER ACTIVE OR PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD PROJECT PHASE: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THAT THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE PROJECT THAT IS THE SUBJECT OF THE AWARD. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THAT THE PI WILL ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LRA. E. PI'S WILLINGNESS TO COMPLETE A BRIEF SURVEY AND SUBMIT A COPY OF THEIR UP-TO-DATE CV TO THE LRA TWO AND FIVE YEARS AFTER THE GRANT END DATE. ALL SI'S RECEIVE A PAYMENT AND DELIVERABLES SCHEDULE AND THE PROJECT IS MONITORED BY: A. PERIODIC PROGRESS REPORTS B. PERIODIC FINAL REPORTS C. ANNUAL MILESTONES SCHEDULE D. ADHERENCE TO LRA TERMS AND CONDITIONS GRANT CHANGES: WHEN EXTENSIONS ARE AWARDED, ADDITIONAL PROGRESS REPORTS AND FINANCIAL REPORTS ARE REQUIRED. AT THE END OF THE GRANT, FINAL PROGRESS AND FINANCIAL REPORTS ARE REQUIRED; UNSPENT AMOUNTS OVER $500 ARE TO BE RETURNED TO THE LRA. A. THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND ORAL OR POSTER PRESENTATIONS. B. THE SI MUST SUBMIT A COPY OF THE IRS DETERMINATION LETTER OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SI.
PART III ACCOUNTING METHOD:

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (1)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

FieldValueIRS element (for citing)
Business Name Line1DS CONSULTING GROUPBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1845 THIRD AVENUE 6TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10022ZIPCd
FieldValueIRS element (for citing)
ActivitySPECIAL EVENT CONSULTANT NY GALAActivityTxt
Fundraiser Control Of FundsYes (1)FundraiserControlOfFundsInd
Gross Receipts$3,914,302GrossReceiptsAmt
Retained By Contractor$65,000RetainedByContractorAmt
Net To Organization$3,914,302NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$3,914,302TotalGrossReceiptsAmt
Total Retained By Contractors$65,000TotalRetainedByContractorsAmt
Total Net To Organization$3,914,302TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDELicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1GALA CELEBRATIONEvent1Nm
Gross Receipts Event1$4,272,623GrossReceiptsEvent1Amt
Charitable Contri Event1$3,897,820CharitableContriEvent1Amt
Gross Revenue Event1$374,803GrossRevenueEvent1Amt
Other Direct Expenses Event1$374,803OtherDirectExpensesEvent1Amt
Event2WALK-A-THONSEvent2Nm
Gross Receipts Event2$1,482,394GrossReceiptsEvent2Amt
Charitable Contri Event2$1,308,485CharitableContriEvent2Amt
Gross Revenue Event2$173,909GrossRevenueEvent2Amt
Rent Facility Costs Event2$15,750RentFacilityCostsEvent2Amt
Food And Beverage Event2$11,175FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$146,984OtherDirectExpensesEvent2Amt
Gross Receipts Total$5,755,017GrossReceiptsTotalAmt
Charitable Contributions Tot$5,206,305CharitableContributionsTotAmt
Gross Revenue Total Events$548,712GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$15,750RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$11,175FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$521,787OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$548,712DirectExpenseSummaryEventsAmt
Net Income Summary$0NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2B, COLUMN (V)FormAndLineReferenceDesc
ExplanationDS CONSULTING PLANNED AND MANAGED LRA'S GALA EVENT. CONTRACT AMOUNT FOR THE PERIOD COVERING 1/1/22 - 12/31/22 WAS $65,000 PLUS REIMBURSABLE EXPENSES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (36 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescPurpose Of GrantPurposeOfGrantTxt
BENAROYA RESEARCH INSTITUTE ATVIRGINIA MASON
1201 9TH AVESEATTLEWA98101910653422501(C)(3)$11,418$0BOOKLUPUS RESEARCH
BOSTON CHILDREN'S HOSPTIAL
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$8,611$0BOOKLUPUS RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL
77 AVENUE LOUIS PASTEURBOSTONMA02115042312909501(C)(3)$166,423$0BOOKLUPUS RESEARCH
BROAD INSTITUTE INC
SEVEN CAMBRIDGE CENTERCAMBRIDGEMA02142263428781501(C)(3)$30,908$0BOOKLUPUS RESEARCH
CHILDREN'S HOSPITAL MEDICAL CENTER CINCINNATI
3333 BURNET AVE MLC 9002CINCINNATIOH45229310833936501(C)(3)$277,504$0BOOKLUPUS RESEARCH
DARTMOUTH-HITCHCOCK CLINIC
1 MEDICAL CENTER DRLEBANONNH03756222519596501(C)(3)$281,461$0BOOKLUPUS RESEARCH
EMORY UNIVERSITY
1762 CLIFTON RD NEATLANTAGA30322580566256501(C)(3)$49,006$0BOOKLUPUS RESEARCH
FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH INC
9650 ROCKVILLE PIKEBETHESDAMD20814521986675501(C)(3)$100,000$0BOOKLUPUS RESEARCH
HOSPITAL FOR SPECIAL SURGERY
535 E 70TH STREETNEW YORKNY10021131624135501(C)(3)$11,481$0BOOKLUPUS RESEARCH
JACKSON LABORATORY
600 MAIN STREETBAR HARBORME04609010211513501(C)(3)$49,006$0BOOKLUPUS RESEARCH
JOHN'S HOPKINS UNIVERSITY
3910 KESWICK ROAD STE N2100BALTIMOREMD21211520595110501(C)(3)$582,761$0BOOKLUPUS RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA02114042697983501(C)(3)$416,389$0BOOKLUPUS RESEARCH
MEDICAL UNIVERSITY OF SOUTH CAROLINA
179 ASHLEY AVENUECHARLESTONSC29425576028985SECTION 115 - SC STA$17,221$0BOOKLUPUS RESEARCH
MONTEFIORE MEDICAL CENTER
111 EAST 210TH STREETBRONXNY10467131740114501(C)(3)$25,000$0BOOKLUPUS RESEARCH
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
550 FIRST AVENUENEW YORKNY10016135562308501(C)(3)$474,748$0BOOKLUPUS RESEARCH
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT BERKELEY
2200 UNIVERSITY AVEBERKELEYCA94720946002123501(C)(3)$8,611$0BOOKLUPUS RESEARCH
ST JUDE CHILDREN'S HOSPITAL
262 DANNY THOMAS PLMEMPHISTN381053678620646012501(C)(3)$929,380$0BOOKLUPUS RESEARCH
STANFORD UNIVERSITY
3145 PORTER DRIVEPALO ALTOCA94304941156365501(C)(3)$291,389$0BOOKLUPUS RESEARCH
STATE UNIVERSITY OF NY AT STONY BROOK
ONE LINCOLN CENTERSYRACUSENY13202141368361501(C)(3)$8,610$0BOOKLUPUS RESEARCH
TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
3601 4TH STREETLUBBOCKTX79430752668014TX STATE GOVERMENT$26,044$0BOOKLUPUS RESEARCH
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
350 COMMUNITY DRIVEMANHASSETNY11030112673595501(C)(3)$3,390,307$0BOOKLUPUS RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC0934LA JOLLACA92093956006144501(C)(3)$8,611$0BOOKLUPUS RESEARCH
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUE STE 501CHICAGOIL60637362177139501(C)(3)$11,178$0BOOKLUPUS RESEARCH
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
6000 FELDWOOD ROADCOLLEGE PARKGA30349566001393501(C)(3)$87,085$0BOOKLUPUS RESEARCH
TULANE UNIVERSITY AKA THE TULANE EDUCATIONAL FUND
200 BROADWAY ST STE 120NEW ORLEANSLA70118720423889501(C)(3)$29,369$0BOOKLUPUS RESEARCH
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE SBIRMINGHAMAL35294636005396501(C)(3)$29,369$0BOOKLUPUS RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
2200 UNIVERSITY HALLBERKELEYCA94720946036493501(C)(3)$8,611$0BOOKLUPUS RESEARCH
UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS
3100 MARINE ST 6TH FLBOULDERCO80309846000555501(C)(3)$10,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF FLORIDA
207 TIGERT HALLGAINSEVILLEFL32611596002052FL STATE GOVERMENT$296,844$0BOOKLUPUS RESEARCH
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655043167325MA STATE GOVERMENT$580,139$0BOOKLUPUS RESEARCH
UNIVERSITY OF MICHIGAN
503 THOMPSON STREETANN ARBORMI48109386006309501(C)(3)$571,547$0BOOKLUPUS RESEARCH
UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
2500 NORTH STATE STREETJACKSONMS39216646008520501(C)(3)$20,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF ROCHESTER
518 HYLAN BUILDINGROCHESTERNY14627160743209501(C)(3)$571,547$0BOOKLUPUS RESEARCH
UNIVERSITY OF WASHINGTON
3917 UNIVERSITY WAY NESEATTLEWA98195916001537SECTION 115 - WA STA$30,000$0BOOKLUPUS RESEARCH
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DRIVENASHVILLETN37232352528741501(C)(3)$41,725$0BOOKLUPUS RESEARCH
YALE UNIVERSITY
BOX 208239NEW HAVENCT06520060646973501(C)(3)$1,029,380$0BOOKLUPUS RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org23Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

FieldValueIRS element (for citing)
Grant TypeLUPUS EMERGENCY GRANT - $500 MAX PER PERSONGrantTypeTxt
Recipient181RecipientCnt
Cash Grant$82,232CashGrantAmt
Valuation Method UsedBILLSValuationMethodUsedDesc
Non Cash AssistanceLUPUS EMERGENCY GRANT - $500 MAX PER PERSONNonCashAssistanceDesc

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, DURING THE APPLICATION PHASE, THE SPONSORING INSTITUTION (SI) MUST AGREE THAT THEY WILL AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S GRANT-SPECIFIC POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: A. CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. B. AGREE THAT THE PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THROUGHOUT THE PROJECT PERIOD. C. AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. D. AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. E. AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. F. TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING - FORUM FOR DISCOVERY. G. CONFIRMATION THAT THERE IS NO OTHER ACTIVE OR PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD PROJECT PHASE: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THAT THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE PROJEC TTHAT IS THE SUBJECT OF THE AWARD. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THAT THE PI WILL ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LRA. E. PI'S WILLINGNESS TO COMPLETE A BRIEF SURVEY AND SUBMIT A COPY OF THEIR UP-TO-DATE CV TO THE LRA TWO AND FIVE YEARS AFTER THE GRANT END DATE. ALL SI'S RECEIVE A PAYMENT AND DELIVERABLES SCHEDULE AND THE PROJECT IS MONITORED BY: A. PERIODIC PROGRESS REPORTS B. PERIODIC FINAL REPORTS C. ANNUAL MILESTONE SCHEDULE D. ADHERENCE TO LRA TERMS AND CONDITIONS GRANT CHANGES: WHEN EXTENSIONS ARE AWARDED, ADDITIONAL PROGRESS REPORTS AND FINANCIAL REPORTS ARE REQUIRED. AT THE END OF THE GRANT, FINAL PROGRESS AND FINANCIAL REPORTS ARE REQUIRED; UNSPENT AMOUNTS OVER $500 ARE TO BE RETURNED TO THE LRA. THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND ORAL OR POSTER PRESENTATIONS. THE SI MUST SUBMIT A COPY OF THE IRS DETERMINATION LETTER OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SI.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ALBERT ROY
CEO AND PRESIDENT$274,569$0$60,000$0$1,634$0$30,500$0$53,623$0$420,326$0$0$0
KENNETH M FARBER
CEO AND PRESIDENT (PAST)$393,795$0$0$0$12,781$0$31,000$0$31,583$0$469,159$0$0$0
DEBRA ROSE
VP AND CHIEF FINANCE OFFICER$193,200$0$30,000$0$2,960$0$25,116$0$24,169$0$275,445$0$0$0
TEODORA STAEVA
VP AND CHIEF SCIENTIFIC OFFICER$267,534$0$50,000$0$1,979$0$24,800$0$43,828$0$388,141$0$0$0
ANDREA O'NEILL
VP AND CHIEF DEVELOPMENT OFFICER$226,600$0$50,000$0$1,823$0$30,426$0$20,818$0$329,667$0$0$0
PENELOPE MITCHELL
VP OF COMMUNICATIONS$173,933$0$10,000$0$2,522$0$14,123$0$24,919$0$225,497$0$0$0
JONATHAN MARKS
DIRECTOR OF CORPORATE DEVELOPMENT$146,200$0$1,000$0$931$0$16,192$0$35,189$0$199,512$0$0$0
DEVON KELLY
LUPUS NEXUS DIRECTOR$155,175$0$2,500$0$2,126$0$13,192$0$24,218$0$197,211$0$0$0
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANTHROPY$169,200$0$5,000$0$3,229$0$19,162$0$21,531$0$218,122$0$0$0
DIANE GROSS
NATIONAL DIRECTOR OF ADVOCACY$142,946$0$750$0$1,385$0$15,807$0$31,247$0$192,135$0$0$0
EBONY SCOTT
HEALTH EQUITY DIRECTOR$133,900$0$2,500$0$479$0$10,507$0$23,529$0$170,915$0$0$0

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution10ContributionCnt
Noncash Contributions Rpt F990$270,634NoncashContributionsRptF990Amt
Method Of Determining RevenuesAVG STOCK VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (1)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 32B:FormAndLineReferenceDesc
ExplanationLRA HAS AN ACCOUNT WITH MORGAN STANLEY, WHICH LRA USES TO SELL THE CONTRIBUTIONS IT RECEIVES THOUGH STOCKS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 2IRA AKSELRAD AND ROBERT WOOD JOHNSON, IV (PAST CHAIRMAN OF THE BOARD), HAVE A BUSINESS RELATIONSHIP. RICHARD K. DESCHERER (CO-CHAIR) AND JENNIE DESCHERER HAVE A FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BAFTER PREPARATION OF FORM 990 BY LRA'S AUDITOR, LUTZ AND CARR, THE 990 IS REVIEWED BY THE LRA'S EXECUTIVE OFFICERS, THE CHIEF FINANCIAL OFFICER AND THE PRESIDENT. THE FINANCE AND AUDIT COMMITTEE OF THE BOARD THEN MEETS TO REVIEW THE 990 BEFORE FILING AND APPROVES FOR FILING WITH ANY NOTED CHANGES. A DRAFT OF THE 990 IS THEN SENT OUT TO THE FULL BOARD FOR COMMENT PRIOR TO FILING WITH THE IRS. THE FINAL FORM 990 IS PRESENTED TO THE FULL BOARD AT THE NEXT SCHEDULED MEETING.
FORM 990, PART VI, SECTION B, LINE 12CTHE GOVERNANCE COMMITTEE OF THE BOARD IS RESPONSIBLE FOR MONITORING CONFLICTS OF INTEREST. AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM IS REQUIRED TO BE FILLED OUT EACH YEAR BY BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES.
FORM 990, PART VI, SECTION B, LINE 15THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTED THE BOARD IN FULFILLING ITS OVERSIGHT RESPONSIBILITIES RELATING TO THE COMPENSATION AND BENEFITS OF THE PRESIDENT AND OTHER EXECUTIVE OFFICERS; AND PROVIDED RECOMMENDATIONS REGARDING MANAGEMENT SUCCESSORS. ANNUALLY THE COMMITTEE REVIEWS AND RECOMMENDS TO THE BOARD THE SALARY FOR THE PRESIDENT AND OTHER OFFICERS/KEY EMPLOYEES. IN 2022, THE COMMITTEE REVIEWED AND APPROVED BASE SALARIES, ANNUAL COST OF LIVING ADJUSTMENTS AND BONUSES FOR ALL STAFF.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST, THE CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE ALSO AVAILABLE UPON REQUEST AND ARE ON THE FINANCIALS PAGE OF OUR WEBSITE AND ON GUIDESTAR.ORG
FORM 990, PART XI, LINE 9:REFUND OF GRANTS 9,771. CANCELLED GRANTS 4,854,118. IMPAIRMENT LOSS ON OPERATING LEASE RIGHT-OF0USE ASSET -1,910,103.
FORM 990, PART V, QUESTION 2ATHE LRA CONTRACTS WITH TRINET, A PROFESSIONAL EMPLOYER ORGANIZATION (PEO), TO PROVIDE PAYROLL AND BENEFITS AS A CO-EMPLOYER WITH THE LRA. LRA PAYROLL AND BENEFITS ARE ADMINISTERED BY TRINET AS APPROVED BY LRA OFFICERS. LRA PAYROLL IS THEREFORE UNDER THE TRINET EIN: 13-3867443 AND W-2'S ARE PREPARED UNDER THAT EIN BY TRINET.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1LUPUS THERAPEUTICS LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd
FieldValueIRS element (for citing)
EIN823984908EIN
Primary ActivitiesLRA'S CLINICAL TRIAL AFFILIATE, OVERSEEING CLINICAL RESEARCH ACTIVITYPrimaryActivitiesTxt
Legal Domicile StateNYLegalDomicileStateCd
Total Income$1,942,523TotalIncomeAmt
End Of Year Assets$1,314,491EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1YESBusinessNameLine1Txt